Mechanobiological conditioning of mesenchymal stem cells for enhanced vascular regeneration

Human mesenchymal stem cells can be mechanically and pharmacologically conditioned to enhance vascular regeneration in vivo, as shown in mice with hindlimb ischaemia. Using endogenous mesenchymal stem cells for treating myocardial infarction and other cardiovascular conditions typically results in poor efficacy, in part owing to the heterogeneity of the harvested cells and of the patient responses. Here, by means of high-throughput screening of the combinatorial space of mechanical-strain level and of the presence of particular kinase inhibitors, we show that human mesenchymal stem cells can be mechanically and pharmacologically conditioned to enhance vascular regeneration in vivo. Mesenchymal stem cells conditioned to increase the activation of signalling pathways mediated by Smad2/3 (mothers against decapentaplegic homolog 2/3) and YAP (Yes-associated protein) expressed markers that are associated with pericytes and endothelial cells, displayed increased angiogenic activity in vitro, and enhanced the formation of vasculature in mice after subcutaneous implantation and after implantation in ischaemic hindlimbs. These effects were mediated by the crosstalk of endothelial-growth-factor receptors, transforming-growth-factor-beta receptor type 1 and vascular-endothelial-growth-factor receptor 2. Mechanical and pharmacological conditioning can significantly enhance the regenerative properties of mesenchymal stem cells.

Automated summary

Human mesenchymal stem cells can be conditioned mechanically and pharmacologically to enhance vascular regeneration in vivo. This conditioning increases the activation of signaling pathways and ultimately improves the regenerative properties of the stem cells, providing a potential treatment option for cardiovascular conditions like myocardial infarction.